These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3990349)

  • 1. Continuous long term heparin therapy--dosage problems using an Infusaid device.
    Späth G; Helber MU; Eisele R
    Life Support Syst; 1985; 3(1):57-9. PubMed ID: 3990349
    [No Abstract]   [Full Text] [Related]  

  • 2. Heparin therapy.
    Geelhoed GW
    Am Fam Physician; 1979 Jun; 19(6):23, 26. PubMed ID: 452983
    [No Abstract]   [Full Text] [Related]  

  • 3. [Problems of heparin dosage].
    Mombelli G
    Schweiz Med Wochenschr; 1984 Apr; 114(15):524-8. PubMed ID: 6729418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Heparin and antiheparin in childhood. 3. Heparin level measurements and their importance in heparin monitoring].
    Domula M; Weissbach G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(1):146-61. PubMed ID: 6192049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin therapy-part I.
    Caprini JA; Zoellner JL; Weisman M
    Cardiovasc Nurs; 1977; 13(3):13-6. PubMed ID: 585587
    [No Abstract]   [Full Text] [Related]  

  • 6. Relation between the time to achieve the lower limit of the APTT therapeutic range and recurrent venous thromboembolism during heparin treatment for deep vein thrombosis.
    Hull RD; Raskob GE; Brant RF; Pineo GF; Valentine KA
    Arch Intern Med; 1997 Dec 8-22; 157(22):2562-8. PubMed ID: 9531224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized trial comparing activated thromboplastin time with heparin assay in patients with acute venous thromboembolism requiring large daily doses of heparin.
    Levine MN; Hirsh J; Gent M; Turpie AG; Cruickshank M; Weitz J; Anderson D; Johnson M
    Arch Intern Med; 1994 Jan; 154(1):49-56. PubMed ID: 8267489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood-sampling strategy for monitoring continuous intravenous heparin therapy.
    Chenella FC; Klotz TA; Gill MA; Paulson YJ; Noguchi JK; Hurst AK; Robinson DC; Hill-Besinque K; Clifford CM; McGehee WG
    Clin Pharm; 1986 Jun; 5(6):510-3. PubMed ID: 3720219
    [No Abstract]   [Full Text] [Related]  

  • 9. [Monitoring of heparin therapy in thromboembolism].
    Hiller E
    Dtsch Med Wochenschr; 1973 Jul; 98(28):1367-70. PubMed ID: 4716792
    [No Abstract]   [Full Text] [Related]  

  • 10. An implantable pump for long-term intravascular drug infusion.
    Blackshear PJ; Rohde TD; Dorman FD; Buchwald H
    Med Instrum; 1981; 15(4):226-8. PubMed ID: 6457965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic heparin anticoagulant in dogs by continuous infusion with a totally implantable pump.
    Rhode TD; Blachshear PJ; Varco RL; Buchwald H
    Trans Am Soc Artif Intern Organs; 1975; 21():510-5. PubMed ID: 1146026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unfractionated heparin therapy in infants and children.
    Newall F; Johnston L; Ignjatovic V; Monagle P
    Pediatrics; 2009 Mar; 123(3):e510-8. PubMed ID: 19221154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of continuous flow heparin in resuscitation].
    Scalet M; Cornu P
    Anesth Analg (Paris); 1977; 34(6):1239-41. PubMed ID: 350091
    [No Abstract]   [Full Text] [Related]  

  • 14. The management of patients on chronic Coumadin therapy undergoing subsequent surgical procedures.
    Madura JA; Rookstool M; Wease G
    Am Surg; 1994 Jul; 60(7):542-6; discussion 546-7. PubMed ID: 8010570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of the subcutaneous heparin pump during pregnancy.
    Barss VA; Schwartz PA; Greene MF; Phillippe M; Saltzman D; Frigoletto FD
    J Reprod Med; 1985 Dec; 30(12):899-901. PubMed ID: 4078826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of heparin on prothrombin time.
    Sawyer WT; Raasch RH
    Clin Pharm; 1984; 3(2):192-4. PubMed ID: 6723228
    [No Abstract]   [Full Text] [Related]  

  • 17. [Double-blind cross-over controlled study on a calcium-heparin preparation].
    Marsala F
    Clin Ter; 1985 Jun; 113(6):473-7. PubMed ID: 3896621
    [No Abstract]   [Full Text] [Related]  

  • 18. The importance of initial heparin treatment on long-term clinical outcomes of antithrombotic therapy. The emerging theme of delayed recurrence.
    Hull RD; Raskob GE; Brant RF; Pineo GF; Valentine KA
    Arch Intern Med; 1997 Nov; 157(20):2317-21. PubMed ID: 9361572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticoagulation by constant subcutaneous heparin infusion.
    Parrilla N; Ansell J
    Thromb Haemost; 1982 Feb; 47(1):1-2. PubMed ID: 7071800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of heparin therapy. Sensitivity of the activated partial thromboplastin time for monitoring the antithrombotic effects of heparin.
    Zucker S; Cathey MH
    J Lab Clin Med; 1969 Feb; 73(2):320-6. PubMed ID: 5764028
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.